Health Care / Chemicals & Pharmaceuticals
Congressional stock trading activity sourced from STOCK Act financial disclosures.
Federal contract context is also available for matched USAspending recipients tied to ABT.
Total Trades
113
Members
34
Purchases
60
Sales
51
Avg Conflict
19 / 100
High Conflict
5
Total disclosed volume: $2,031,113 - $8,540,000 · Latest trade: Jul 30, 2026
Matched federal spending records can add context when a heavily traded company is also receiving public money. These recipient matches come from USAspending and should be read alongside, not instead of, the underlying trade filings.
Matched recipients
4
Tracked awards
3,152
Matched spending
$137.6M
ABBOTT LABORATORIES matches USAspending recipient ABBOTT LABORATORIES INC., with approximately $92,574,024 in tracked federal spending during the queried window.
ABBOTT LABORATORIES matches USAspending recipient ABBOTT LABORATORIES, with approximately $21,375,170 in tracked federal spending during the queried window.
19
Members
62
Trades
26 / 100
Avg Score
15
Members
51
Trades
12 / 100
Avg Score
8 Form 4 transactions by 3 insiders in the last 90 days. Buys and sales below count open-market transactions only — Form 4 codes P and S. Grants, option exercises and shares withheld for tax move the share count but are not decisions to trade.
Open-market buys
0
Open-market sales
3
Net shares, all codes
−6,691
Buys per sale
0.00
| Insider | Role | Date | Transaction | Shares | Price | Total Value | Filing |
|---|---|---|---|---|---|---|---|
| Ford Robert B | CHAIRMAN AND CEO | Aug 25, 2026 |
One card per congressional trade. Where several insiders filed in the same window, the card names the largest and counts the rest.
Julie Johnson sold ABT 5 days after Stratton John G, Director, reported bought on a Form 4.
Kelly Armstrong sold ABT 4 days after ORVILLE JACOB A, Senior Vice President, reported granted on a Form 4.
| Date▼ | Member↕ | Type↕ | Amount↕ | Owner | Conflict↕ |
|---|---|---|---|---|---|
| Jul 30, 2026 | Richard McCormick | sale | $1,001 - $15,000 | self | -- |
| Jul 17, 2026 | Mike Kelly | sale | $1,001 - $15,000 | spouse | -- |
| Jul 14, 2026 | Rick W. Allen | sale | $15,001 - $50,000 | spouse | 30 / 100 |
| Jul 8, 2026 | Rick Larsen | sale | $1,001 - $15,000 | self | -- |
| Jun 16, 2026 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Jun 12, 2026 | Richard McCormick | purchase | $1,001 - $15,000 | self | -- |
| May 27, 2026 | Josh Gottheimer | sale | $1,001 - $15,000 | joint | -- |
| May 15, 2026 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| May 12, 2026 | Julie Johnson | sale | $1,001 - $15,000 | joint | -- |
| Apr 16, 2026 | Rick W. Allen | sale | $15,001 - $50,000 | spouse | 30 / 100 |
| Mar 27, 2026 | Kelly Armstrong | sale | $15,001 - $50,000 | self | -- |
| Mar 24, 2026 | Laura Friedman | exchange | $1,001 - $15,000 | self | 35 / 100 |
| Mar 19, 2026 | Richard McCormick | purchase | $1,001 - $15,000 | self | 36 / 100 |
| Feb 10, 2026 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| Jan 29, 2026 | Thomas H. Kean, Jr. | purchase | $1,001 - $15,000 | self | 63 / 100 |
| Jan 29, 2026 | Thomas H. Kean, Jr. | purchase | $1,001 - $15,000 | self | 63 / 100 |
| Dec 19, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Dec 19, 2025 | Gilbert Ray Cisneros, Jr. | sale | $1,001 - $15,000 | self | -- |
| Dec 18, 2025 | Julie Johnson | sale | $1,001 - $15,000 | joint | 36 / 100 |
| Dec 8, 2025 | Julia Letlow | sale | $1,001 - $15,000 | self | 31 / 100 |
| Dec 4, 2025 | Byron Donalds | sale | $1,001 - $15,000 | spouse | -- |
| Dec 4, 2025 | Byron Donalds | sale | $1,001 - $15,000 | self | -- |
| Dec 4, 2025 | Byron Donalds | sale | $1,001 - $15,000 | self | -- |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
| Nov 18, 2025 | Gilbert Ray Cisneros, Jr. | purchase | $1,001 - $15,000 | self | -- |
Other Health Care stocks traded by members of Congress.
ABBOTT LABORATORIES matches USAspending recipient ABBOTT LABORATORIES INC., with approximately $15,289,267 in tracked federal spending during the queried window.
ABBOTT LABORATORIES matches USAspending recipient ABBOTT LABORATORIES INC., with approximately $8,351,958 in tracked federal spending during the queried window.
| 218,535 |
| $115.57 |
| $25.3M |
| SEC Filing |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25, 2026 | Open-market sale | 180,297 | $116.19 | $20.9M | SEC Filing |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25, 2026 | Option exercise | 246,963 | $59.94 | $14.8M | SEC Filing |
| Ford Robert B | CHAIRMAN AND CEO | Aug 25, 2026 | Option exercise | 151,869 | $44.40 | $6.7M | SEC Filing |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Aug 12, 2026 | Code I | 12 | $107.99 | $1,296 | SEC Filing |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Aug 11, 2026 | Open-market sale | 5,850 | $109.83 | $642,506 | SEC Filing |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Jun 30, 2026 | Shares withheld for tax | 269 | $92.71 | $24,939 | SEC Filing |
| Cushman Elizabeth C. | EVP, GC AND SECRETARY | Jun 27, 2026 | Shares withheld for tax | 560 | $94.12 | $52,707 | SEC Filing |
| Stratton John G | Director | May 7, 2026 | Open-market buy | 2,000 | $86.82 | $173,640 | SEC Filing |
| Moreland Mary K | EXECUTIVE VICE PRESIDENT | Apr 28, 2026 | Code I | 5,314 | $94.41 | $501,695 | SEC Filing |
| STARKS DANIEL J | Director | Apr 27, 2026 | Open-market buy | 10,000 | $92.65 | $926,537 | SEC Filing |
| STARKS DANIEL J | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| McKinstry Nancy | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| Conroy Kevin T | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| Stratton John G | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| O'Grady Michael | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| Blount Sally E. | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| Roman Michael F | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| Kumbier Michelle | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
| Babineaux-Fontenot Claire | Director | Apr 24, 2026 | Grant or award | 2,286 | $0.00 | $0 | SEC Filing |
AbbVie Inc.